PRKACB antibody (N-Term)
Quick Overview for PRKACB antibody (N-Term) (ABIN928850)
Target
See all PRKACB AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purification
- Purified
-
Immunogen
- PRKACB antibody was raised in rabbit using the N terminal of PRKACB as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
PRKACB Blocking Peptide, (ABIN5615552), is also available for use as a blocking control in assays to test for specificity of this PRKACB antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PRKACB (Protein Kinase, CAMP Dependent, Catalytic, beta (PRKACB))
-
Alternative Name
- PRKACB
-
Background
- CAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Synonyms: Polyclonal PRKACB antibody, Anti-PRKACB antibody, protein kinase, cAMP-dependent, catalytic, beta antibody, DKFZp781I2452 antibody, MGC41879 antibody, MGC9320 antibody, PKACB antibody.
-
Pathways
- AMPK Signaling, Hedgehog Signaling, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Lipid Metabolism
Target
-